HEBECELL
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases the company's mission is to contribute to the fields of regenerative medicine and immuno-oncology by developing cell-based therapeutics. It produces cancer-specific natural killer (NK) cells that are developing while suspended in a liquid solution within a bioreactor, allowing them to reproduce indefinitely.
HEBECELL
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2016-01-01
Address:
Natick, Massachusetts, United States
Country:
United States
Website Url:
http://www.hebecellcorp.com
Total Employee:
11+
Status:
Active
Contact:
+1 508 545 2190
Email Addresses:
[email protected]
Total Funding:
63 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Creative BioTherapeutics
Creative BioTherapeutics discovers treatments for patients with incurable diseases.
EchoPixel
EchoPixel develops medical imaging devices that enable doctors to use CT images of a patient’s abdomen and display a 3D model.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
FimmCyte
FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.
Longeviti
Longeviti develops and commercializes implantable neurosurgical devices.
Okami Medical
Okami Medical develops and commercializes new devices for the treatment of heart disease.
Z.M.D. Medical
Z.M.D. Medical develops and commercializes a therapeutic remedy to cure cancer of all types using the immune system.
Current Employees Featured
Founder
Investors List
Jacobio Pharmaceuticals
Jacobio Pharmaceuticals investment in Series A - HebeCell
Aceso Biotech Venture Fund
Aceso Biotech Venture Fund investment in Seed Round - HebeCell
Official Site Inspections
http://www.hebecellcorp.com Semrush global rank: 6.56 M Semrush visits lastest month: 954
- Host name: ded5116.inmotionhosting.com
- IP address: 173.231.203.136
- Location: El Segundo United States
- Latitude: 33.9214
- Longitude: -118.413
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90245
More informations about "HebeCell"
About - Hebecellcorp
Lily is the VP of Finance and Administration of HebeCell Corp. Prior to joining HebeCell, she was the VP of Accounting and Operations of Vcanbio USA where she played a critical role of building up the corporate operating infrastructure …See details»
HebeCell - Crunchbase Company Profile & Funding
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases the company's mission is to contribute to the fields of regenerative medicine and immuno …See details»
HEBECELL CORP. Company Profile | Natick, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for HEBECELL CORP. of Natick, MA. Get the latest business insights from Dun & Bradstreet.See details»
HebeCell Company Profile 2024: Valuation, Funding
HebeCell General Information Description. Developer of a biotechnology systems intended to improve immuno-oncology and regenerative medicine. The company offers technology and research to eliminate exhaustive feeder-dependent …See details»
HebeCell Corp - LinkedIn
HebeCell Corp | 1,923 followers on LinkedIn. HebeCell is a Natick, MA based biotech company that focuses on immuno-oncology and regenerative medicine. | HebeCell was founded in 2016 by a group of ...See details»
Our Team - Hebecellcorp
21 Strathmore Rd, Natick, MA, 01760, United States +1 (508) 545- 2190 [email protected]See details»
HebeCell - Work in biotech
HebeCell Corp is developing cell-based therapeutics to treat incurable diseases. Named after the Greek Goddess of Youth, HebeCell is using their patented scalable natural killer (NK) cell …See details»
HebeCell - Overview, News & Similar companies | ZoomInfo.com
Apr 6, 2022 www.hebecellcorp.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. HebeCell and Logomix Announce Collaboration …See details»
Hebecellcorp Company Profile | Management and Employees List
Find contact information for Hebecellcorp. Learn about their Custom Software & IT Services, Business Services market share, competitors, and Hebecellcorp's email format.See details»
HebeCell Company Profile - Office Locations, Competitors ... - Craft
HebeCell has 5 employees at their 1 location. See insights on HebeCell including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
HebeCell Corp. (HebeCell Corp.) - 药物管线_专利_临床试验_投融营 …
了解HebeCell Corp. (HebeCell Corp.)公司的药物管线，治疗领域，技术平台，以及它的12篇新闻和3篇文献，疾病领域:肿瘤，血液及淋巴系统疾病，内分泌与代谢疾病，神经系统疾病，技术 …See details»
HebeCell and Logomix Announce Collaboration for the …
Aug 14, 2023 HebeCell’s team includes multiple world-leading experts in stem cell biology, as well as experienced entrepreneurs and business developers. The company operates a fully …See details»
HebeCell CEO and Key Executive Team | Craft.co
HebeCell's President and CEO is John Lu. Other executives include Allen Feng, Chief Scientific Officer; Edmund Mickunas, Vice President Regulatory Affairs and Quality Assurance and 1 …See details»
John Lu, Ph.D, MPH – Hebecellcorp
21 Strathmore Rd, Natick, MA, 01760, United States +1 (508) 545- 2190 [email protected]See details»
HebeCell Raises $53 Million in Series A Financing to ... - Business …
Aug 31, 2021 HebeCell announces closing of successful US$53 million Series A financing to advance unique off-the-shelf PSC-CAR-NK products into clinics.See details»
HebeCell and Logomix Announce Collaboration for the …
Aug 11, 2023 For more please see: https://hebecellcorp.com About Logomix Logomix is a Tokyo-based synthetic biology company, maximizing the potential of cells by its Mb-scale and …See details»
HebeCell Raises $53 Million in Series A Financing to Advance …
NATICK, Mass.–(BUSINESS WIRE)–HebeCell Corp (“HebeCell”) today announced that it has successfully closed a US$53 million Series A financing to advance its unique off-the-shelf …See details»
Careers - Hebecellcorp
21 Strathmore Rd, Natick, MA, 01760, United States +1 (508) 545- 2190 [email protected]See details»
News – Hebecellcorp
Apr 24, 2020 Proteintech and HebeCell announce their collaborative partnership to develop proprietary nanobody based chimeric antigen receptor (nCAR) technology for the development …See details»